Emerging agents and regimens for hepatocellular carcinoma
Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer mortality globally. Most patients need at least one systemic therapy at different phases of their treatment for HCC. S...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Xiao-Dong Zhu and Hui-Chuan Sun Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology